| Inventor | Institute |
|---|---|
| Stephen West | Cancer Research UK, London Research Institute: Clare Hall Laboratories |
| SKU: | 151238 |
|---|---|
| Product description: | DMC1 is a meiosis-specific homologue of RecA/RAD51 and is an essential component of the meiotic recombination machinery in yeast and higher eukaryotes. |
| Alternate name: | Disrupted meiotic cDNA 1 homolog, Disrupted meiotic cDNA 1, yeast homolog of, dJ199H16.1, DMC 1, DMC1, DMC1 dosage suppressor of mck1 homolog, DMC1 dosage suppressor of mck1 homolog meiosis specific homologous recombination (yeast), DMC1 homologue |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | human DMC1 protein (expressed as 6xHis fusion in E. coli) |
| Myeloma used: | Sp2/0-Ag14 |
| Cat. #: | 151238 |
|---|---|
| Provenance and Ownership: | The Anti-DMC1 [1D12/4] is owned by Cancer Research UK. CancerTools supplies the Anti-DMC1 [1D12/4] under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-DMC1 [1D12/4] directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Genetics |
| Application: | IHC ; IP ; WB |
| Target: | DMC1 |
| Reactivity: | Human |
| Clone: | 1D12/4 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | DMC1 is a meiosis-specific homologue of RecA/RAD51 and is an essential component of the meiotic recombination machinery in yeast and higher eukaryotes. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Masson JY et al. 1999. EMBO J. 18(22):6552-60. PMID: 10562567 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.